SPX -0.34% VIX 1.42%
HOUSE DEMOCRATS VOTE TO CONDEMN TRUMPS RACIST TWEETS 
STOCKS END LOWER, RETREATING FROM RECORDS AFTER TRUMP STOKES TRADE UNCERTAINTY 
U.S. MANUFACTURING IS IN RECESSION: FED DATA 
TESLA DROPS CHEAPER MODEL S, MODEL X OPTIONS 
SHORT COVERING PLAYS PART AS BLUE APRON ROCKETS 50% ON BEYOND MEAT NEWS 
HBOS GAME OF THRONES GETS RECORD-BREAKING 32 EMMY NOMINATIONS 
TRUMP AGREES WITH ALLY AND FACEBOOK BOARD MEMBER THAT GOOGLE SHOULD BE PROBED 
THINK YOUR INCOME LEVEL IS TOO HIGH FOR A ROTH IRA? THINK AGAIN 
GOLDMAN SACHS SHARES HELP DOW MAINTAIN INTRADAY GAIN 
DOW TAPS ALL-TIME INTRADAY HIGH AS INVESTORS WEIGH BIG-BANK EARNINGS 
Wed, Jul 17 4:41am


Mylan NV [MYL]
$18.43 0.54 (2.85%)

MYL Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 9.91 Billion
MYL Description

Registered in the Netherlands, Mylan is a leading generic drugmaker, with roughly 55 manufacturing and R&D facilities. Although the company was formed in 1961, the company's position as the second-largest generic company was largely attributable to the acquisition of Matrix Laboratories and generics business of Germany-based Merck KGaA. Mylan has a portfolio of more than 7,500 generic, specialty, and over-the-counter active ingredients and medicines and is predominantly recognized for manufacturing the EpiPen (treatment for anaphylaxis), which was acquired through the Merk KGaA transaction.


Visit Website

MYL Earnings

EPS -0.05 P/E Ratio 28.88
Previous Earnings Tue, Feb 26, 2019
Latest Earnings Tue, May 7, 2019 (71 days ago) -34.78%

MYL Dividend

Yield --
Ex-Date --
Pay Date --
History 73 Payments (Quarterly)

MYL Charts

$16.63
52 Week Range
$39.49
May 31, 2019
Sep 5, 2018



Symbol Price Day % YTD %
MYL $18.43 -2.85% -33.99%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy